The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility

NCT ID: NCT00829751

Last Updated: 2013-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to more objectively evaluate potential lens-material/care solution bio-incompatibilities. We will do this by measuring corneal staining and the amount of fluorescein dye diffusion into the eye.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Lens Solution Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ReNu Multiplus

Purevision lenses will be soaked in ReNu Multiplus

Group Type ACTIVE_COMPARATOR

PureVision lenses soaked in ReNu Multiplus

Intervention Type DEVICE

Purevision silicone hydrogel lenses

OptiFree RePlenish

PureVision lenses will be soaked in OptiFree RePlenish

Group Type ACTIVE_COMPARATOR

PureVision lenses soaked in OptiFree RePlenish

Intervention Type DEVICE

Purevision silicone hydrogel lenses soaked in OptiFree RePlenish

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PureVision lenses soaked in ReNu Multiplus

Purevision silicone hydrogel lenses

Intervention Type DEVICE

PureVision lenses soaked in OptiFree RePlenish

Purevision silicone hydrogel lenses soaked in OptiFree RePlenish

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age.
* Best correctable vision to 20/40 in each eye.
* Possess a functional spectacle prescription to allow adequate vision during the de-adaptation and fluorometry measurement period.
* No known ocular or systemic allergies, which may interfere with contact lens wear.
* No known systemic disease, or need for medication that may interfere with contact les wear (i.e. antihistamines, beta-blockers, steroids, ect.).

Exclusion Criteria

* Subjects demonstrating any medical condition that may affect the results of this study SHOULD NOT be enrolled. The following are specific conditions that exclude subjects from enrollment in this study.
* Eye (ocular) or systemic allergies that may interfere with contact lens wear.
* Clinically significant corneal swelling (greater than 3 or 4 on a 0-4 scale), corneal blood vessel growth (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
* Are taking part in any other study or have taken part in a study within the last 14 days.
* Are pregnant, or anticipating to become pregnant during the course of the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role collaborator

Southern California College of Optometry at Marshall B. Ketchum University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jerry R. Paugh, OD, PhD

Professor, Associate Dean for Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jerry R Paugh, OD, PhD

Role: PRINCIPAL_INVESTIGATOR

Southern California College of Optometry at Marshall B. Ketchum University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern California College of Optometry

Fullerton, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.